Publications by authors named "Michael Cher"

Claim this Profile
P
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Michael L Cher, Evan Goldfischer

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Michael L Cher, Evan Goldfischer

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Michael L Cher, Evan Goldfischer

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Sticky Are Clinical Trial Interventions? Site-Level Clinical Trial Participation and Differential Post-Trial Use of a Genomic Test.
Patrick Lewicki, Ralph Jiang, Udit Singhal, Stephanie Daignault-Newton, Kevin Ginsburg, Michael Cher

JCO Oncol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Rupture During Partial Nephrectomy: More Questions than Answers.
Brian R Lane, Michael L Cher, Lauren E Lane

Eur Urol Open Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial.
Todd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, Rodney L Dunn, Udit Singhal, Michael L Cher

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Autophagy-Targeting Chimera Induces Degradation of Androgen Receptor Mutants and AR-v7 in Castration-Resistant Prostate Cancer.
Tae Hyun Bae, Ki Woon Sung, Tri M Pham, Abdo J Najy, Alaleh Zamiri, Michael L Cher

Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).
Jinping Xu, Cathryn H Bock, James Janisse, Justin Woo, Michael L Cher

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?
Michael Wang, Sophie Wittenberg, Michael L Cher, Monica Van Til, Stephanie Ferrante

Eur Urol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can MRI Help Inform Which Men With a History of Multifocal High-Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?
Michael S Sessine, Codrut S Radoiu, Ji Qi, Corinne Labardee, Frank Burks, Michael L Cher

J Urol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.
Barani Govindarajan, Diego Sbrissa, Mark Pressprich, Seongho Kim, Arun K Rishi, Michael L Cher

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance.
Michael Wang, Andrew Lange, David Perlman, Ji Qi, Arvin K George, Michael L Cher

Prostate· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Interaction between Chemokine and Phosphoinositide Signaling in Metastatic Prostate Cancer.
Codrut Radoiu, Barani Govindarajan, Michael Wang, Diego Sbrissa, Michael L Cher

Med Res Arch· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of a Statewide Active Surveillance Initiative: A Roadmap for Increasing Active Surveillance Utilization Nationwide.
Randy A Vince, Yilun Sun, Brandon Mahal, Kevin Ginsburg, Arvin George, Michael Cher

Eur Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.
Barani Govindarajan, Diego Sbrissa, Mark Pressprich, Seongho Kim, Ulka Vaishampayan, Michael L Cher

Res Sq· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative Experience.
Roshan Paudel, Raghav Madan, Ji Qi, Stephanie Ferrante, Michael L Cher

J Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Roshan Paudel, Raghav Madan, Ji Qi, Stephanie Ferrante, Michael L Cher

J Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
Karim Chamie, Sam S Chang, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Michael L Cher, Evan Goldfischer

NEJM Evid· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trials in the Key of G: Building Level 1 Evidence on the Real-world Effectiveness of Prostate Biomarkers.
Linda A Okoth, Anna C Harris, Udit Singhal, Michael L Cher, Daniel E Spratt

Eur Urol Focus· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice-Level Variation in the Decision to Biopsy Prostate Imaging-Reporting and Data System 3 Lesions in Favorable-Risk Prostate Cancer Patients.
Derek Versalle, Ji Qi, Sabrina L Noyes, Andrew Moriarity, Arvin George, Michael L Cher

Urology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added influence of genomics and post-MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillance.
Michael Wang, Ji Qi, Arvin K George, Alice Semerjian, Susan M Linsell, Michael L Cher

Prostate· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed radical prostatectomy after a period of active surveillance is not associated with the use of secondary treatments compared with immediate prostatectomy.
Rohith Arcot, Michael L Cher, Ji Qi, Susan M Linsell, Rodney L Dunn

Prostate· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol.
Jinping Xu, Michael Goodman, James Janisse, Michael L Cher, Cathryn Hufford Bock

BMJ Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of lymph node yield with overall survival in patients with pathologically node negative prostate cancer.
Kevin B Ginsburg, Mark F Pressprich, Hallie A Wurst, Michael L Cher

Curr Probl Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation?
Tarek Taha, Wei Phin Tan, Ahmed Elshafei, Alireza Aminsharifi, Robert Given, Michael L Cher

Curr Urol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis